Chemical formula: C₁₈H₂₇NO₃ Molecular mass: 305.412 g/mol PubChem compound: 1548943
Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
M02AB01 | Capsaicin | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AB Capsaicin and similar agents |
N01BX04 | Capsaicin | N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BX Other local anesthetics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
QUTENZA Cutaneous patch | European Medicines Agency (EU) | MPI, EU: SmPC |
Capsaicin is an active ingredient of these brands:
Austria (AT)Croatia (HR)Cyprus (CY)Ecuador (EC)Finland (FI)France (FR)Israel (IL)Italy (IT)Japan (JP)
Lithuania (LT)Malta (MT)Netherlands (NL)Poland (PL)South Africa (ZA)Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.